Oncology imaging is among the platform's principal applications, where spatial resolution and tissue characterisation both bear on assessment. The Gemstone detector delivers up to 230-micron resolution, and where the spectral licence is fitted, monoenergetic reconstruction and material density mapping support characterisation beyond what single-energy acquisition provides. Virtual non-contrast series can also be derived from a contrast acquisition rather than requiring a separate unenhanced scan. All clinical judgement, including whether an examination is justified, remains with the referring and reporting clinicians, and Medigear.uk supplies configuration and condition detail rather than clinical guidance.
Cardiac work is served by the 0.35-second gantry rotation together with the detector's stated cardiac resolution improvement, though whether cardiac licences such as SnapShot and CardIQ are fitted is confirmed rather than assumed, since they are separately licensed. A scanner capable of cardiac acquisition but not licensed for it cannot perform the work.
Neurological and whole-organ perfusion work, and low-dose lung assessment, appear among the platform's stated applications. Which of them a given unit supports again depends on the licence list rather than the model name, and two scanners of identical age and model can differ substantially on that basis. Medigear.uk supplies the fitted list in writing before any offer is made.
Services planning a purchase should assess remaining tube life against their own throughput rather than an industry average. A tube fitted in 2024 is favourable, but a high-volume list consumes tube life considerably faster than intermittent outpatient work, so Medigear.uk provides accumulated mAs and scan seconds to make that assessment possible.



